Product NDC: | 36000-033 |
Proprietary Name: | Metoprolol |
Non Proprietary Name: | metoprolol tartrate |
Active Ingredient(s): | 5 mg/5mL & nbsp; metoprolol tartrate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 36000-033 |
Labeler Name: | Claris Lifesciences Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078950 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120925 |
Package NDC: | 36000-033-10 |
Package Description: | 10 VIAL in 1 CARTON (36000-033-10) > 5 mL in 1 VIAL |
NDC Code | 36000-033-10 |
Proprietary Name | Metoprolol |
Package Description | 10 VIAL in 1 CARTON (36000-033-10) > 5 mL in 1 VIAL |
Product NDC | 36000-033 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | metoprolol tartrate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120925 |
Marketing Category Name | ANDA |
Labeler Name | Claris Lifesciences Inc. |
Substance Name | METOPROLOL TARTRATE |
Strength Number | 5 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |